Board of Directors
Paul R. Edick
Chairman and CEO, Xeris Pharmaceuticals
Mr. Edick is a member and Chairperson of Milestone’s board of directors. Mr. Edick is currently Chairman and CEO of Xeris Pharmaceuticals (Nasdaq: XERS). Mr. Edick was most recently Founding Partner of 3G Advisors, a consultancy to the Pharmaceutical, Healthcare and Healthcare Investor communities.
From July 2010 until November 2014, Mr. Edick was the Chief Executive Officer of Durata Therapeutics, (Nasdaq: DRTX).
Prior to starting Durata, Mr. Edick was CEO of Ganic Pharmaceuticals, a Warburg Pincus funded investment search vehicle, from 2008 to 2010. Before Ganic, Mr. Edick was CEO of MedPointe Healthcare Inc.. Mr. Edick assumed the CEO role in 2006, having been President of Pharmaceutical Operations since 2002. Mr. Edick led the growth of the commercial business, the development of a clinical stage portfolio and the negotiated sale of MedPointe to Meda AB of Sweden in 2007.
Mr. Edick also has extensive industry experience with leading consumer, pharmaceutical and healthcare organizations.
Mr. Edick holds a BA in Psychology from Hamilton College.